SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-019789
Filing Date
2023-02-13
Accepted
2023-02-13 16:52:16
Documents
1
Group Members
ROCHE HOLDING LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236317_sc13ga.htm SC 13G/A 60696
  Complete submission text file 0001104659-23-019789.txt   62504
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-56243 | Film No.: 23619415
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
Business Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
ROCHE FINANCE LTD (Filed by) CIK: 0001053942 (see all company filings)

State of Incorp.: V8
Type: SC 13G/A